Skip to search formSkip to main contentSkip to account menu

ASP015K

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract 1. Although marked gender differences have been reported for the exposure level of the sulfate metabolite M2 of ASP015K… 
2014
2014
Background ASP015K is a novel oral Janus kinase (JAK) inhibitor in development for the treatment of rheumatoid arthritis (RA… 
2013
2013
Background ASP015K is an oral Janus kinase (JAK) inhibitor with selectivity for JAK1/3 in development for treatment of rheumatoid… 
2013
2013
Background ASP015K is an oral Janus kinase (JAK) inhibitor with moderate selectivity for JAK3, a key enzyme for interleukin-2 (IL… 
2013
2013
Background Janus kinase (JAK) enzymes play key roles in cytokine signaling and are important in the pathology of autoimmune… 
2013
2013
Background ASP015K is an oral Janus kinase (JAK) inhibitor of JAK1/3 in development for treatment of autoimmune diseases (eg…